SCHEMBL4388768

SCHEMBL4388768

CCCC(=O)OC(C)C(CCCCC(=O)O)(C(=O)O)C(C)OC(=O)CCC

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.40
AKR1B1 P15121 1/20 0.40
GPR84 Q9NQS5 7/20 0.39
PPARG P37231 7/20 0.39
PPARD Q03181 7/20 0.39
PPARA Q07869 7/20 0.39
HDAC11 Q96DB2 5/20 0.39
TSHR P16473 4/20 0.39
PTPN1 P18031 3/20 0.39
ALDH1A1 P00352 3/20 0.39
TLR2 O60603 2/20 0.39
TDP1 Q9NUW8 2/20 0.39
FABP4 P15090 2/20 0.39
KMT2A Q03164 2/20 0.39
FFAR1 O14842 2/20 0.39
FFAR4 Q5NUL3 2/20 0.39
SLC22A6 Q4U2R8 1/20 0.39
SLC22A8 Q8TCC7 1/20 0.39
MEN1 O00255 1/20 0.39
ESR1 P03372 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4384310 0.98 LMNA (0.42) LMNAAKR1B1GPR84PPARGPPARD
SCHEMBL4394578 0.98 LMNA (0.42) LMNAAKR1B1GPR84PPARGPPARD
SCHEMBL4382997 0.98 LMNA (0.42) LMNAAKR1B1GPR84PPARGPPARD
SCHEMBL4386097 0.98 LMNA (0.42) LMNAAKR1B1GPR84PPARGPPARD
SCHEMBL4390867 0.98 LMNA (0.42) LMNAAKR1B1GPR84PPARGPPARD
SCHEMBL4382415 0.95 ALDH1A1 (0.38) LMNAAKR1B1GPR84PPARGPPARD
SCHEMBL4392589 0.91 LMNA (0.53) LMNAAKR1B1GPR84PPARGPPARD
SCHEMBL4382126 0.91 LMNA (0.53) LMNAAKR1B1GPR84PPARGPPARD
SCHEMBL4384371 0.91 LMNA (0.53) LMNAAKR1B1GPR84PPARGPPARD
SCHEMBL4395387 0.91 LMNA (0.53) LMNAAKR1B1GPR84PPARGPPARD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7629383-B2 Double esters DRUG DISCOVERY LABORATORY AS (NO) 2009-12-08 US disclosed
US-20050203181-A1 Double esters DRUG DISCOVERY LABORATORY AS (NO) 2005-09-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050203181-A1 Double esters ACACA, CES1, ACACB LMNA 1955/4885AKR1B1 512/4885GPR84 982/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.